When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACHN - Ra Pharma's zilucoplan shows favorable PK profile in renal impairment patients expanding potential clinical programs
Achison Inc Cl A
Results from a Phase 1b assessing the pharmacokinetics of Ra Pharmaceuticals' (NASDAQ:RARX) RA101495 SC (zilucoplan) in patients with severe renal impairment showed a similar profile compared to healthy patients. There were no adverse events reported and the data indicate that no adjustments in dose need to be made in these patients.
More news on: Ra Pharmaceuticals, Apellis Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., Healthcare stocks news,